Interestingly, in the TME A2AR activation has been reported to reduce the production of those tumor eradicating cytokines IL-6, IL-17, and IFN-γ that in the present study we found downmodulated in tumor-bearing p2x7−/− mice (Augustin et al., 2022). This evidence concerns the gene IL17A and neoplasm.